Abcellera Biologics Inc (ABCL)

Nov 13, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024

Nov 11, 2024

AbCellera Biologics (NASDAQ:ABCL) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Nov 11, 2024

Nov 08, 2024

Bloom Burton Cuts Earnings Estimates for AbCellera Biologics - MarketBeat

Nov 08, 2024

Nov 07, 2024

Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Abcellera Biologics Inc (ABCL-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 - Business Wire

Nov 07, 2024

Nov 07, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St

Nov 07, 2024

Nov 07, 2024

Leerink Partnrs Has Pessimistic View of ABCL FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 07, 2024

AbCellera Unveils Breakthrough T-Cell Platform Data, Shows Promise in Cancer Treatment | ABCL Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Given "Hold" Rating at Benchmark - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Given "Buy" Rating at Stifel Nicolaus - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down After Earnings Miss - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera stock price target cut, keeps Outperform on strategic pivot By Investing.com - Investing.com UK

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

Nov 05, 2024

Nov 05, 2024

Earnings call: AbCellera reports steady Q3 2024 revenue amidst R&D growth - Investing.com

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Developments - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance

Nov 05, 2024

Nov 04, 2024

AbCellera Reports Q3 2024 Business Results - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

AbCellera Biologics Reports Q3 2024 Financial Results - TipRanks

Nov 04, 2024

Nov 04, 2024

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript - Nasdaq

Nov 04, 2024

Nov 04, 2024

Nasdaq Insurance Index (INSR) QuotePress Release - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

TSX Industrials Capped Index (TTIN) QuotePress Release - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

Abcellera Biologics earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK

Nov 04, 2024

Nov 04, 2024

AbCellera Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024

Nov 03, 2024

McDonald's Corp (MCD-N) QuotePress Release - The Globe and Mail

Nov 03, 2024

Nov 03, 2024

Laureate Education Inc (LAUR-Q) QuotePress Release - The Globe and Mail

Nov 03, 2024

Nov 01, 2024

AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To K - GuruFocus.com

Nov 01, 2024

Oct 30, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Oct 30, 2024

Oct 29, 2024

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Oct 29, 2024

Oct 28, 2024

AbCellera Biologics (ABCL) Set to Announce Quarterly Earnings on Monday - MarketBeat

Oct 28, 2024

Oct 23, 2024

TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail

Oct 23, 2024

Oct 22, 2024

AbCellera to Present at Upcoming Investor Conferences in November 2024 - Business Wire

Oct 22, 2024

Oct 21, 2024

3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap - Yahoo Finance

Oct 21, 2024

Oct 16, 2024

Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts? - Insider Monkey

Oct 16, 2024

Oct 14, 2024

AbCellera Biologics (NASDAQ:ABCL) Shares Down 5%Here's What Happened - MarketBeat

Oct 14, 2024

Oct 14, 2024

AbCellera: A Platform To Pipeline Transition - Seeking Alpha

Oct 14, 2024

Oct 07, 2024

AbCellera Biologics (NASDAQ:ABCL) Trading Up 5.2%Here's What Happened - MarketBeat

Oct 07, 2024

Oct 04, 2024

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 - Lucknow Sentinel

Oct 04, 2024

Sep 28, 2024

Dark Forest Capital Management LP Buys 45,721 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World

Sep 28, 2024

Sep 28, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Acquired by Renaissance Technologies LLC - MarketBeat

Sep 28, 2024

Sep 28, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Receives $14.20 Average Price Target from Analysts - MarketBeat

Sep 28, 2024

Sep 27, 2024

Wall Street SWOT: AbCellera stockBiotech firm's platform shows promise amid challenges - Investing.com

Sep 27, 2024

Sep 27, 2024

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 - BioSpace

Sep 27, 2024